Ranked API manufacturers
01 China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for enoxaparin, filing since 2005. Its 2018 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Last FDA inspection
2018 · VAI
GMP recognised in
2 markets
02 China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2020. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 5 markets.
Last FDA inspection
2025 · NAI
GMP recognised in
5 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2012. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Last FDA inspection
2024 · NAI
GMP recognised in
2 markets
04 China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds 2 active US DMFs for enoxaparin, filing since 2013. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Last FDA inspection
2019 · VAI
GMP recognised in
6 markets
05 India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one valid CEP for enoxaparin, filing since 2024. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Last FDA inspection
2024 · VAI
GMP recognised in
19 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2017. Its 2025 FDA inspection closed as NAI.
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2017. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2025. Its 2025 FDA inspection closed as VAI.
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
09 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2008.
Last FDA inspection
Not established
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2011. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2025.
Last FDA inspection
Not established
GMP recognised in
Not established
Holds one active US DMF for enoxaparin, filing since 2018.
Last FDA inspection
Not established
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for enoxaparin, filing since 2014.
Last FDA inspection
Not established
GMP recognised in
Not established
10 more manufacturers hold filings for enoxaparin
The names are listed below. The filings, inspection history and GMP certificates behind
each one are available with a free account.
Open the full list with a free account Contract manufacturers (5)
Contract manufacturers make to order rather than holding their own filing for this
molecule.
Finished-dose makers (33)
How this list is built
The order is set by active filings weighted by regulator, inspection outcomes and their
recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags.
Every factor appears on the card it produced.
Read the full method.
- Active US DMFs
- FDA, List of Drug Master Files
- Valid CEPs
- EDQM certificate database
- Inspection outcomes
- FDA inspection classifications
- GMP certificates
- EudraGMDP and national regulators